Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
48.56
-0.06 (-0.12%)
At close: Mar 6, 2026, 4:00 PM EST
48.71
+0.15 (0.31%)
After-hours: Mar 6, 2026, 7:00 PM EST
Veradermics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Veradermics stock have an average target of 78.33, with a low estimate of 75 and a high estimate of 85. The average target predicts an increase of 61.31% from the current stock price of 48.56.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Veradermics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 |
|---|---|
| Strong Buy | 2 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2026 |
| Citigroup | Citigroup | Strong Buy Initiates $85 | Strong Buy | Initiates | $85 | +75.04% | Mar 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $75 | Buy | Initiates | $75 | +54.45% | Mar 2, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +54.45% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.